Profile
Dr. Roger Léger is Founder at Ulysses Pharmaceuticals Pvt Ltd. and Vice President-Research Consulting at Indel Therapeutics, Inc. Dr. Léger was previously employed as a Director-Medicinal Chemistry by ConjuChem Biotechnologies, Inc., a Principal by Essential Therapeutics, Inc., and Vice President-Research by Ulysses Pharmaceuticals Products, Inc.
Roger Léger active positions
| Companies | Position | Start |
|---|---|---|
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 29/10/2012 |
Former positions of Roger Léger
| Companies | Position | End |
|---|---|---|
Ulysses Pharmaceuticals Pvt Ltd.
Ulysses Pharmaceuticals Pvt Ltd. Pharmaceuticals: OtherHealth Technology Provides homeopathic modern medicines | Founder | - |
ConjuChem Biotechnologies, Inc.
ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Corporate Officer/Principal | - |
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical goods for viral and fungal infections | Corporate Officer/Principal | - |
Ulysses Pharmaceuticals Products, Inc.
Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Ulysses Pharmaceuticals Products, Inc.
Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections | Health Technology |
ConjuChem Biotechnologies, Inc.
ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ulysses Pharmaceuticals Pvt Ltd.
Ulysses Pharmaceuticals Pvt Ltd. Pharmaceuticals: OtherHealth Technology Provides homeopathic modern medicines | Health Technology |
- Stock Market
- Insiders
- Roger Léger
















